MD Anderson recently welcomed His Highness Sheikh Hamed Bin Zayed Al Nahyan, Chairman of the Crown Prince Court of Abu Dhabi; His Excellency Mohamed Haji Al Khoori, Director General of the Khalifa Bin Zayed Al Nahyan Foundation; and H.E. Yousef Al Otaiba, United Arab Emirates Ambassador to the United States, to dedicate the Sheikh Zayed Bin Sultan al Nahyan Building for Personalized Cancer Care. Construction was made possible through a $150 million grant by the Khalifa Foundation in 2011 to accelerate the pace of personalized cancer therapies and pancreatic cancer research.
The 12-floor, 628,652-square-foot building, now in the second phase of construction, houses the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, the Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, and molecular diagnostics, histocompatibility and molecular pathology research laboratories.
The grant also funds three distinguished university chairs as well as a Faculty Scholar program to advance the discovery and delivery of effective and accessible personalized cancer treatments.
"This dedication marks a significant milestone for MD Anderson and the patients we serve around the world," says Ronald DePinho, M.D., president of MD Anderson. "We are grateful to the Khalifa Foundation for its visionary contribution to Making Cancer History®.